Orchestra BioMed Holdings (OBIO) Operating Income (2022 - 2025)
Historic Operating Income for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to -$20.3 million.
- Orchestra BioMed Holdings' Operating Income fell 2429.94% to -$20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.2 million, marking a year-over-year decrease of 2517.76%. This contributed to the annual value of -$64.3 million for FY2024, which is 2484.18% down from last year.
- Latest data reveals that Orchestra BioMed Holdings reported Operating Income of -$20.3 million as of Q3 2025, which was down 2429.94% from -$19.3 million recorded in Q2 2025.
- Orchestra BioMed Holdings' Operating Income's 5-year high stood at -$5.1 million during Q1 2022, with a 5-year trough of -$20.3 million in Q3 2025.
- Its 4-year average for Operating Income is -$13.8 million, with a median of -$14.4 million in 2024.
- In the last 5 years, Orchestra BioMed Holdings' Operating Income crashed by 12513.65% in 2023 and then crashed by 1251.72% in 2024.
- Quarter analysis of 4 years shows Orchestra BioMed Holdings' Operating Income stood at -$9.8 million in 2022, then fell by 26.99% to -$12.5 million in 2023, then plummeted by 33.62% to -$16.7 million in 2024, then decreased by 21.8% to -$20.3 million in 2025.
- Its Operating Income was -$20.3 million in Q3 2025, compared to -$19.3 million in Q2 2025 and -$18.9 million in Q1 2025.